156.3 ð©º å §ç§å°ç§èåç
156.3.0.1 1ïžâ£ çºäœ Listeria Important?
- Mortality é« (~ 20-30% è人, ~ 50% æ°çå )
- Empirical meningitis å¿ é cover (幎霡 + å ç« risk)
- 飿º outbreak æçº (2011 cantaloupe 33æ», 2024 deli/çç±³/cookies)
156.3.0.2 2ïžâ£ Meningitis Empirical Algorithm
| Age / Risk | Empirical Cocktail |
|---|---|
| < 1 mo | Amp + cefotaxime/gentamicin |
| 1 mo - 50 yr healthy | Vanco + ceftriaxone ± dex |
| > 50 yr / å ç«äœäž / EtOH | Vanco + ceftriaxone + AMPICILLIN ± dex |
| Post-NSGY | Vanco + cefepime/meropenem |
156.3.0.3 3ïžâ£ Rhombencephalitis
- Listeria ç¹è² (brainstem; éå¥ Bickerstaff brainstem encephalitis, TB)
- Sx: cranial neuropathy + cerebellar ataxia + altered mentation
- MRI: brainstem T2 â
- LP: 坿£åžž protein/glucose äœ CSF cx +
- æ²»ç longer (21-28d)
156.3.0.4 4ïžâ£ Pregnancy
- éå ± Public Health
- Amp ASAP (å³äœ¿æ·ç â å culture æ ¢)
- Bridge with TMP-SMX åš 1st/3rd trimester é¿å (folate, kernicterus)
- Postpartum æ²»ç mother + æ°çå (å³äœ¿ asymptomatic, sepsis workup)
156.3.0.5 5ïžâ£ Cephalosporin Intrinsic R
- PBP3 affinity äœ
- ç¶é©åŒ meningitis empirical å¿ å amp (⥠50 æ risk)
- äžçš ceftriaxone monotherapy